Alembic Pharmaceuticals Ltd Board of Directors
Board of Directors at Alembic Pharmaceuticals Ltd
Independent Director
Independent Director
Chairman & CEO
Independent Director
Independent Director
Key Highlights
- C R Amin joins the board as Executive Chairman, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Rajkumar Baheti joins the board as Non Independent Executive Director / CFO, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Pranav Amin joins the board as ED / MD / Promoter, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Shaunak Amin joins the board as ED / MD / Promoter, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
- Ashok Barat joins the board as Independent Non Exe. Director, in a new position in 2026. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Alembic Pharmaceuticals Ltd
NSE: APLLTD
Share Price
Last Ten Days Market Price
| Date | |
|---|---|
| 23 Oct 2026 | 758.75 |
| 22 Oct 2026 | 780.7 |
| 21 Oct 2026 | 788.15 |
| 19 Oct 2026 | 790.2 |
| 16 Oct 2026 | 788.4 |
| 15 Oct 2026 | 791.6 |
| 14 Oct 2026 | 792.3 |
| 13 Oct 2026 | 797.1 |
| 12 Oct 2026 | 787.65 |
| 09 Oct 2026 | 801.05 |
Company Fundamentals for Alembic Pharmaceuticals Ltd
Market Cap
14,914 Cr
EPS
38.0
P/E Ratio (TTM)
20.0
P/B Ratio (TTM)
2.6
Day’s High
791.45
Day’s Low
748.8
DTE
0.3
ROE
11.9
52 Week High
998.0
52 Week Low
635.3
ROCE
10.8
Market Price of Alembic Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Alembic Pharmaceuticals Ltd News Hub
Alembic Pharma receives USFDA approval for Dabigatran Etexilate Capsules
Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) f
Read more
13 Aug 24
Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa
Read more
13 Aug 24
Alembic Pharmaceuticals Ltd leads losers in 'A' group
Steel Authority of India Ltd, IFCI Ltd, Coffee Day Enterprises Ltd and Orient Cement Ltd are among t
Read more
09 Aug 24
Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
Revenue from operations grew 5.09% year on year (YoY) to Rs 1,561.73 crore in the quarter ended 30 J
Read more
08 Aug 24
Document
Concalls
